Seeking Alpha

Adam Feuerstein weighs in (video) on the upcoming FDA decision on a lung inhaler from Alexza...

Adam Feuerstein weighs in (video) on the upcoming FDA decision on a lung inhaler from Alexza Pharmaceuticals (ALXA +0.8%), saying that an approval is "not a sure bet" and is too close to call. Trading volume in ALXA spiked higher after the biotech analyst's comments were distributed and digested, although shares only traced up moderately.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)